ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus

Eur J Endocrinol. 2020 Aug;183(2):G49-G56. doi: 10.1530/EJE-20-0401.

Abstract

The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate.

MeSH terms

  • Adult
  • Betacoronavirus
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / transmission
  • Diabetes, Gestational / diagnosis*
  • Endocrinology / methods*
  • Endocrinology / standards
  • Female
  • Humans
  • Obstetrics / methods*
  • Obstetrics / standards
  • Pandemics / prevention & control
  • Pneumonia, Viral / prevention & control
  • Pneumonia, Viral / transmission
  • Practice Guidelines as Topic*
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Complications, Infectious / virology
  • Prenatal Care / methods*
  • Prenatal Care / standards

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2